"Le Centre Ophtalmologique Rabelais est une structure de soins spécialisée dans l’imagerie ophtalmologique et dans la prise en charge des maladies rétiniennes"

During the past decade, Centre d'Ophtalmologie Rabelais conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre d'Ophtalmologie Rabelais" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Drescode" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centre d'Ophtalmologie Rabelais" are "Macular Degeneration" (2 trials), "Exudative Age-related Macular Degeneration" (1 trials), "Eye Diseases" (1 trials), "Geographic Atrophy" (1 trials) and "Retinal Degeneration" (1 trials). Many other conditions were trialed in "Centre d'Ophtalmologie Rabelais" in a lesser frequency.

Most popular intervention types in "Centre d'Ophtalmologie Rabelais" are "Drug" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Nutrof Total" (1 trials), "Sham" (1 trials), "Software as medical device" (1 trials) and "Zimura" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre d'Ophtalmologie Rabelais" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centre d'Ophtalmologie Rabelais". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre d'Ophtalmologie Rabelais, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre d'Ophtalmologie Rabelais, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".